Skip to Main Content

Paper Details

Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALL.
Sci Adv
61
2022
ALL, CAR, CAR T cells, CAR T infusion product, CD19, T cell, acute lymphoblastic leukemia, chimeric, chimeric antigen receptor, deficiency of T helper 2 function, early memory T cells, patients, single-cell transcriptomes
Author NameAffiliation
David M BarrettChildren's Hospital of Philadelphia
David M BarrettChildren's Hospital of Philadelphia
Stephan A GruppChildren's Hospital of Philadelphia
Stephan A GruppChildren's Hospital of Philadelphia
Carl H JunePerelman School of Medicine, University of Pennsylvania
Carl H JuneCenter for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania
Carl H JuneParker Institute for Cancer Immunotherapy at University of Pennsylvania
Pablo G CamaraDepartment of Genetics and Institute for Biomedical Informatics, University of Pennsylvania
  • 1 - 8

Datasets

Release 1.2